Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Madisonville, KY
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Madisonville, KY
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Owensboro, KY
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Marrero, LA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Marrero, LA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Annapolis, MD
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Annapolis, MD
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Catonsville, MD
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Catonsville, MD
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Oxon Hill, MD
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Towson, MD
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Towson, MD
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Marlborough, MA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Marlborough, MA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Quincy, MA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Quincy, MA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Kalamazoo, MI
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Port Gibson, MS
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Port Gibson, MS
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Chesterfield, MO
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Saint Louis, MO
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Missoula, MT
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Missoula, MT
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Omaha, NE
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Las Vegas, NV
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Blackwood, NJ
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Blackwood, NJ
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Egg Harbor City, NJ
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Egg Harbor City, NJ
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Vineland, NJ
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Vineland, NJ
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Albuquerque, NM
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Hopewell Junction, NY
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Hopewell Junction, NY
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Kew Gardens, NY
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Kew Gardens, NY
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
New York, NY
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
New York, NY
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Poughkeepsie, NY
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Chapel Hill, NC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Fayetteville, NC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
High Point, NC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
High Point, NC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Jacksonville, NC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Raleigh, NC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Salisbury, NC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Salisbury, NC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Winston-Salem, NC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Cincinnati, OH
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Columbus, OH
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Dayton, OH
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Franklin, OH
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Franklin, OH
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Kettering, OH
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Kettering, OH
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Mentor, OH
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Mentor, OH
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Middleburg Heights, OH
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Wadsworth, OH
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Wadsworth, OH
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Oklahoma City, OK
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Doylestown, PA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Doylestown, PA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Lansdale, PA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Lansdale, PA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Levittown, PA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Levittown, PA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Philadelphia, PA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Anderson, SC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Greer, SC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Greer, SC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Mount Pleasant, SC
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Fayetteville, TN
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Fayetteville, TN
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Franklin, TN
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Franklin, TN
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Hermitage, TN
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Hermitage, TN
Click here to add this to my saved trials